Skip to content
Agree.net – Lifestyle
Author:
IGC Pharma, Inc.
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts
April 8, 2026
IGC Pharma to Showcase AI Platform with Alzheimer’s Disease Data Initiative at ADPD 2026
March 18, 2026
←
Previous Page
1
2